1. Patrick K, Vora A. Update on biology and treatment of T-cell acute lymphoblastic leukaemia. Curr Opin Pediatr. 2015; 27:44–49. PMID:
25502893.
2. Meijerink JP. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. Best Pract Res Clin Haematol. 2010; 23:307–318. PMID:
21112032.
3. Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM. Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2004; 118–145. PMID:
15561680.
4. Borowitz MJ, Chan JKC. T lymphoblastic leukaemia/lymphoma. In : Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC;2008. p. 176–178.
5. Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood. 2003; 102:262–268. PMID:
12637319.
6. Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013; 27:2165–2176. PMID:
23628958.
7. Yang JJ, Marschalek R, Meyer C, Park TS. Diagnostic usefulness of genomic breakpoint analysis of various gene rearrangements in acute leukemias: a perspective of long distance- or long distance inverse-PCR-based approaches. Ann Lab Med. 2012; 32:316–318. PMID:
22779077.
8. Strehl S, König M, Meyer C, Schneider B, Harbott J, Jäger U, et al. Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Genes Chromosomes Cancer. 2006; 45:1041–1049. PMID:
16897742.
9. Harrison CJ, Cuneo A, Clark R, Johansson B, Lafage-Pochitaloff M, Mugneret F, et al. Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia. 1998; 12:811–822. PMID:
9593286.
10. Beverstock GC, Hoekman K, Kluin-Nelemans JC, Wienhofer E. Reciprocal translocation, t(11;17)(q23-25;q21), in a patient with an immature ALL. Cancer Genet Cytogenet. 1986; 22:83–87. PMID:
3456831.